½ÃÀ庸°í¼­
»óǰÄÚµå
1818075

¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× °¡»óÁø·á ½ÃÀå ¿¹Ãø(-2032³â) - ¼­ºñ½º À¯Çüº°, Á¦°ø ¹æ½Äº°, ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

Telehealth & Virtual Care Market Forecasts to 2032 - Global Analysis By Service Type (Real-Time Virtual Consultations, Remote Patient Monitoring (RPM), and Store-and-Forward Services), Delivery Mode, Component, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ ÀÇÇϸé, ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× °¡»óÁø·á ½ÃÀåÀº 2025³â¿¡ 727¾ï 4,000¸¸ ´Þ·¯¿¡ À̸£°í, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 26.3%·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 3,729¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿ø°ÝÀÇ·á ¹× °¡»óÁø·á¶õ ¸ð¹ÙÀÏ ¾Û, È­»óÅëÈ­, Ä¿³ØÆ¼µå µð¹ÙÀ̽º µî µðÁöÅÐ µµ±¸¸¦ ÀÌ¿ëÇØ ¿ø°ÝÁö¿¡¼­ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ÀǷḦ º¸´Ù Ä£¼÷ÇÏ°Ô ¸¸µé°í, ´ë¸é Áø·áÀÇ Çʿ伺À» ÁÙÀ̸ç, ´õ ³ªÀº ȯÀÚ Âü¿©¸¦ Áö¿øÇÕ´Ï´Ù. ¶ÇÇÑ, ÆíÀǼº°ú È¿À²¼ºÀ» Çâ»ó½ÃŰ¸é¼­ Àû½Ã¿¡ Ä¡·á¸¦ º¸ÀåÇϰí, Áö¹æÀ̳ª ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ªÀ¸·Î ÀÇ·á ¼­ºñ½º¸¦ È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃֽŠÀÇ·á Á¢±Ù ¹æ½ÄÀ¸·Î Ä¡·áÀÇ ¿¬¼Ó¼ºÀ» ÃËÁøÇϰí ÀÇ·á Á¦°ø ½Ã½ºÅÛÀ» ÃÖÀûÈ­ÇÕ´Ï´Ù.

DeloitteÀÇ Á¶»ç¿¡ µû¸£¸é, ¼ÒºñÀÚÀÇ Àý¹Ý ÀÌ»ó(53%)ÀÌ Á¦³Ê·² AI°¡ ÀÇ·á Á¢±Ù¼ºÀ» °³¼±ÇÒ °ÍÀ̶ó°í »ý°¢Çϰí ÀÖÀ¸¸ç, 46%´Â AI°¡ ÀǾàǰ ¹× Ä¡·á ºñ¿ëÀ» Àý°¨Çϰí, ÀÏ»óÀûÀÎ ¹Ì±¹ÀεéÀÌ º¸´Ù Àú·ÅÇÑ °¡°ÝÀ¸·Î ÀÇ·á ¼­ºñ½º¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô ÇØÁÙ °ÍÀ̶ó°í ÀÀ´äÇß½À´Ï´Ù.

Á¢±Ù¼ºÀÌ ÁÁ°í ºñ¿ë È¿À²ÀûÀÎ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

Àú·ÅÇÏ°í ½±°Ô Á¢±ÙÇÒ ¼ö ÀÖ´Â ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ¿ø°Ý ÀÇ·á ¹× °¡»ó ÀÇ·á Ç÷§ÆûÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àα¸ °í·ÉÈ­¿Í ¸¸¼ºÁúȯ Áõ°¡¿¡ µû¶ó ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ ±âÁ¸ÀÇ ´ë¸é Áø·á¿¡ ´ëÇÑ ´ë¾ÈÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ ÅøÀº Áö¹æÀ̳ª ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ªÀÇ °ÝÂ÷¸¦ ÇØ¼ÒÇϰí, Áö¸®Àû Á¦¾à ¾øÀÌ Àû½Ã¿¡ Áø·á¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ³×Æ®¿öÅ©¿Í ½º¸¶Æ®ÆùÀÇ º¸±Þ È®´ë´Â °¡»ó Áø·á·ÎÀÇ ÀüȯÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎ¿Í º¸Çè»çµéÀº º´¿øÀÇ ºÎ´ãÀ» ÁÙÀÌ°í °á°ú¸¦ °³¼±ÇÏ´Â ¿ø°ÝÁø·áÀÇ °¡Ä¡¸¦ Á¡Á¡ ´õ ¸¹ÀÌ ÀνÄÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿äÀÇ ±ÞÁõÀº ¿ø°ÝÀÇ·á »ýŰè Àü¹ÝÀÇ Çõ½Å°ú ÅõÀÚ¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× »çÀ̹ö º¸¾È¿¡ ´ëÇÑ ¿ì·Á

¿ø°Ý ÀÇ·á Ç÷§ÆûÀº µ¥ÀÌÅÍ º¸È£ ¹× »çÀ̹ö º¸¾È Ãë¾à¼º¿¡ ´ëÇÑ °¨½Ã°¡ °­È­µÇ°í ÀÖ½À´Ï´Ù. ±â¹Ð¼ºÀÌ ³ôÀº ȯÀÚ Á¤º¸¸¦ ´Ù·ç±â À§Çؼ­´Â HIPAA, GDPR(EU °³ÀÎÁ¤º¸º¸È£±ÔÁ¤) µî °³ÀÎÁ¤º¸ º¸È£ ±ÔÁ¤À» ¾ö°ÝÇÏ°Ô ÁؼöÇØ¾ß ÇÕ´Ï´Ù. ·¹°Å½Ã ½Ã½ºÅÛÀ̳ª Ÿ»ç ¾Û°úÀÇ ÅëÇÕÀº Ç÷§ÆûÀ» Ä§ÇØ ¹× ¹«´Ü ¾×¼¼½º¿¡ ³ëÃâ½Ãų ¼ö ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Áø·á ¹× ¿þ¾î·¯ºí ±â±âÀÇ µ¥ÀÌÅÍ º¸È£ÀÇ º¹À⼺Àº ¿î¿µ»óÀÇ ¾î·Á¿òÀ» °¡Áß½Ã۰í ÀÖ½À´Ï´Ù. °ø±ÞÀÚ´Â ½Å·Ú¸¦ À¯ÁöÇϱâ À§ÇØ ¾Ïȣȭ, ´Ù´Ü°è ÀÎÁõ, Á¤±âÀûÀÎ °¨»ç¿¡ ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù. ƯÈ÷ ¹ýÀû ±ÔÁ¦°¡ ¾ö°ÝÇϰųª µðÁöÅÐ ¹®ÇØ·ÂÀÌ ³·Àº Áö¿ª¿¡¼­´Â ÀÌ·¯ÇÑ ¿ì·Á·Î ÀÎÇØ µµÀÔ ¼Óµµ°¡ ´À·ÁÁú ¼ö ÀÖ½À´Ï´Ù.

Áö¼ÓÀûÀΠȯÀÚ ¸ð´ÏÅ͸µÀ» À§ÇÑ ¿þ¾î·¯ºí µð¹ÙÀ̽º ÅëÇÕ

¿þ¾î·¯ºí ±â¼ú°ú ¹öÃß¾ó ÄɾîÀÇ À¶ÇÕÀº »çÀü ¿¹¹æÀû °Ç°­°ü¸®ÀÇ »õ·Î¿î °¡´É¼ºÀ» À̲ø¾î³»°í ÀÖ½À´Ï´Ù. ½º¸¶Æ®¿öÄ¡, ¹ÙÀÌ¿À¼¾¼­, ÇÇÆ®´Ï½º Æ®·¡Ä¿¿Í °°Àº ÀåÄ¡´Â »ýü ½ÅÈ£, Ȱµ¿·®, º¹¾à ¼øÀÀµµ¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ µ¥ÀÌÅÍ´Â ¿ø°Ý ÀÇ·á Ç÷§Æû¿¡ ¿øÈ°ÇÏ°Ô ÅëÇյǾî ÀÓ»óÀǰ¡ ¿ø°ÝÀ¸·Î Á¤º¸¿¡ ÀÔ°¢ÇÑ ÆÇ´ÜÀ» ³»¸± ¼ö ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀº ÇÕº´ÁõÀÇ Á¶±â ¹ß°ß°ú ¸ÂÃã Ä¡·á °èȹÀ» Áö¿øÇÕ´Ï´Ù. AI¿Í ¿¹Ãø ºÐ¼®ÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ¿þ¾î·¯ºíÀº ¸¸¼ºÁúȯ °ü¸®¿Í ¿¹¹æÀÇÇп¡¼­ Áß½ÉÀûÀÎ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Çコ Å×Å©¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ ºÐ¾ß ½ÃÀå ±Ô¸ð°¡ Å©°Ô È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á¦ÇÑµÈ ½Åü °Ë»ç·Î ÀÎÇÑ ¿ÀÁø À§Çè

ƯÁ¤ ÁúȯÀÇ °æ¿ì, ¿ø°ÝÀ¸·Î ½ÃÇàÇÒ ¼ö ¾ø´Â ÃËÁø, ¿µ»óÁø´Ü, °Ë»ç½Ç °Ë»ç°¡ ÇÊ¿äÇÕ´Ï´Ù. ȯÀÚ°¡ º¸°íÇÏ´Â Áõ»óÀ̳ª ¿µ»ó ÁøÂû¿¡ Áö³ªÄ¡°Ô ÀÇÁ¸Çϸé ÀÓ»óÀû ÅëÂû·ÂÀÌ ºÒ¿ÏÀüÇØÁú ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À§ÇèÀº ¹Ì¹¦ÇÑ Â¡Èĸ¦ ³õÄ¡±â ½¬¿î º¹ÀâÇÏ°í ±Þ¼ºÀÎ °æ¿ì ƯÈ÷ µÎµå·¯Áý´Ï´Ù. ÀÇ·áÁøÀº ÆíÀǼº°ú ÀÓ»óÀû ¾ö°ÝÇÔÀÇ ±ÕÇüÀ» À¯ÁöÇØ¾ß Çϸç, Á¾Á¾ ȯÀÚ¸¦ ´ë¸é °üÂûÀ» À§ÇØ È¯ÀÚ¸¦ ÀÇ·ÚÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀûÀýÇÑ ÇÁ·ÎÅäÄݰú ¿¡½ºÄ÷¹ÀÌ¼Ç °æ·Î°¡ ¾øÀ¸¸é ¿ø°Ý ÀÇ·á ¼­ºñ½ºÀÇ ½Å·Ú¼ºÀÌ ¼Õ»óµÉ ¼ö ÀÖ½À´Ï´Ù.

Äڷγª19ÀÇ ¿µÇâ

Äڷγª19 »çÅ´ ¿ø°ÝÀÇ·áÀÇ º¸±ÞÀ» ±ØÀûÀ¸·Î °¡¼ÓÈ­Çϰí, Æ´»õ ¼­ºñ½º¿¡¼­ ÁÖ·ù ÀÇ·á ¼Ö·ç¼ÇÀ¸·Î º¯¸ð½ÃÄ×½À´Ï´Ù. Æó¼â¿Í »çȸÀû °Å¸®µÎ±â Àǹ«È­·Î ÀÎÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀº Áø·áÀÇ ¿¬¼Ó¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¿ø°Ý Áø·á·Î ÀüȯÇÒ ¼ö¹Û¿¡ ¾ø´Â »óȲ¿¡ Ã³ÇØ ÀÖ½À´Ï´Ù. ȯÀÚµéÀº ¾ÈÀü°ú Æí¸®ÇÔÀ» Ãß±¸ÇÏ¸ç °¡»ó Ç÷§ÆûÀ» ¹Þ¾Æµé¿´°í, ÀÌ´Â ÀÌ¿ëÀÚ ±ÞÁõÀ¸·Î À̾îÁ³½À´Ï´Ù. ±ÔÁ¦ ±â°üÀº ÀϽÃÀûÀ¸·Î ±ÔÁ¦¸¦ ¿ÏÈ­ÇÏ¿© º¸´Ù ±¤¹üÀ§ÇÑ »óȯ°ú ±¹°æÀ» ÃÊ¿ùÇÑ Áø·á¸¦ °¡´ÉÇÏ°Ô Çß½À´Ï´Ù. ÆÒµ¥¹Í ÀÌÈÄ Àü·«Àº ÇÏÀ̺긮µå ÄÉ¾î ¸ðµ¨, ȸº¹·Â, °¡»ó ¼­ºñ½ºÀÇ Àå±âÀûÀÎ ÅëÇÕ¿¡ ÁßÁ¡À» µÎ°Ô µÇ¾ú½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ½Ç½Ã°£ °¡»ó Áø·á ºÐ¾ß°¡ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ Àü¸Á

½Ç½Ã°£ °¡»ó Áø·á ºÐ¾ß´Â ´Ù¾çÇÑ ÀÇ·á ¼ö¿ä¿¡ Áï°¢ÀûÀ¸·Î ´ëÀÀÇÒ ¼ö ÀÖ´Ù´Â Á¡¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ȯÀÚ ÀÔÀå¿¡¼­´Â Àǻ翡°Ô Áï°¢ÀûÀÎ Á¢±Ù, ´ë±â ½Ã°£ ´ÜÃà, ºÒÇÊ¿äÇÑ À̵¿À» ÇÇÇÒ ¼ö ÀÖ´Ù´Â ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ÀÌ Æ÷¸ËÀº 1Â÷ Áø·á, Á¤½Å °Ç°­, ÈÄ¼Ó Áø·á¿¡ ´ëÀÀÇϰí ÀÖ¾î ´ÙÀç´Ù´ÉÇÕ´Ï´Ù. ÀüÀÚÀǹ«±â·Ï ¹× ½ºÄÉÁÙ °ü¸® ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀº ÀÇ·á Á¦°ø¾÷üÀÇ ¿öÅ©Ç÷οì È¿À²¼ºÀ» ³ôÀÔ´Ï´Ù. Áø·á º¸»ó ¸ðµ¨ÀÌ ÁøÈ­ÇÏ°í »ç¿ëÀÚ °æÇèÀÌ Çâ»óµÊ¿¡ µû¶ó ½Ç½Ã°£ Áø·á°¡ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ±× È®À强°ú ¹ÝÀÀ¼ºÀº °¡»ó ÀÇ·á ¼­ºñ½º Á¦°øÀÇ ÇÙ½ÉÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ÀçÅÃÄ¡·á ¹× ȯÀÚ ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °³ÀÎÈ­µÈ ¿ø°Ý ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÀçÅÃÄ¡·á ¹× ȯÀÚ ºÐ¾ß°¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °í·ÉÈ­¿Í ¸¸¼ºÁúȯÀÇ È®»êÀº ÀçÅà ¸ð´ÏÅ͸µ°ú °¡»ó Áö¿ø¿¡ ´ëÇÑ °ü½ÉÀ» ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á´Â ȯÀÚ°¡ Áý¿¡ ÀÖÀ¸¸é¼­ ´ç´¢º´, °íÇ÷¾Ð, COPD µîÀÇ Áõ»óÀ» °ü¸®ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¿ø°Ý Áø´Ü°ú ¸ð¹ÙÀÏ °Ç°­ ¾ÛÀÇ ¹ßÀüÀº °³ÀÎÀÌ ÀÚ½ÅÀÇ °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖ´Â ±ÇÇÑÀ» ºÎ¿©Çϰí ÀÖ½À´Ï´Ù. °£º´ÀÎÀ̳ª °¡Á·µéµµ ¿¬°è¼º Çâ»ó°ú ½Ç½Ã°£ ÃֽŠÁ¤º¸¸¦ ÅëÇØ ÇýÅÃÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº ȯÀÚ Áß½ÉÀÇ ºÐ»êÇü Áø·á ¸ðµ¨·Î ÀüȯÇÏ´Â ±¤¹üÀ§ÇÑ º¯È­¸¦ ¹Ý¿µÇÕ´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª:

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¹æ´ëÇÑ Àα¸¿Í ÀÇ·áÀÇ µðÁöÅÐÈ­·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áß±¹, Àεµ, ÀϺ»°ú °°Àº ±¹°¡µéÀº ³óÃÌÀÇ Á¢±Ù¼º °ÝÂ÷ ¹× µµ½ÃÁö¿ªÀÇ È¥ÀâÀ» ÇØ¼ÒÇϱâ À§ÇØ ¿ø°ÝÀÇ·á ÀÎÇÁ¶ó¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ ¹× ¸ð¹ÙÀÏ ÆÛ½ºÆ® Àü·«À» ÃßÁøÇÏ´Â Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê°¡ äÅÃÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ Ã·´Ü ±â¼ú¿¡ Á¤ÅëÇÑ ¼ÒºñÀÚ¿Í È®´ëµÇ´Â Áß»êÃþÀÌ Æí¸®ÇÑ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹Î°ü ÆÄÆ®³Ê½ÊÀÌ Çõ½Å°ú È®À强À» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, À̴ ÷´Ü ±â¼ú ÅëÇÕ°ú Áö¿øÀûÀÎ Á¤Ã¥ ÇÁ·¹ÀÓ¿öÅ©¿¡ ÈûÀÔÀº °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù. ¹Ì±¹°ú ij³ª´Ù´Â AI¸¦ Ȱ¿ëÇÑ Áø´Ü, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, °¡»ó Çൿ ÀÇ·á ¼­ºñ½º¸¦ ¼±µµÇϰí ÀÖ½À´Ï´Ù. ¿¬¹æÁ¤ºÎÀÇ ÀçÁ¤ Áö¿ø°ú º¸ÇèÁ¦µµ °³ÇõÀ¸·Î º´¿ø ¹× Áø·á¼Ò¿¡¼­ äÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ½ºÅ¸Æ®¾÷°ú ±âÁ¸ ±â¾÷ ¸ðµÎ »ç¿ëÀÚ °æÇè, »óÈ£¿î¿ë¼º, µ¥ÀÌÅÍ ºÐ¼®¿¡ ÀÖ¾î Çõ½ÅÀû ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ÀÇ·áºñ »ó½Â°ú ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü ºÎÁ·À¸·Î ÀÎÇØ ÀÌÇØ°ü°èÀÚµéÀº È®Àå °¡´ÉÇÑ °¡»ó ¼Ö·ç¼ÇÀ¸·Î ´«À» µ¹¸®°í ÀÖ½À´Ï´Ù. ¼º¼÷ÇÑ µðÁöÅÐ »ýŰ踦 °¡Áø ºÏ¹Ì´Â ¿ø°ÝÀÇ·áÀÇ Çõ½Å°ú ¼ºÀåÀÇ º¥Ä¡¸¶Å· ´ë»óÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ ¼­ºñ½º

º» º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ¼Ò°³
    • Ãß°¡ ±â¾÷ Á¾ÇÕ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ±¸ºÐ
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­·Ð

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • ºÐ¼® ¹üÀ§
  • ºÐ¼® ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • ºÐ¼® Á¢±Ù
  • ºÐ¼® ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå PorterÀÇ Five Forces ºÐ¼®

  • °ø±Þ¾÷üÀÇ ±³¼··Â
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • ´ëü Á¦Ç°ÀÇ À§Çù
  • ½Å±Ô Âü¿© ±â¾÷ÀÇ À§Çù
  • ±â¾÷°£ °æÀï

Á¦5Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× °¡»óÁø·á ½ÃÀå : ¼­ºñ½º À¯Çüº°

  • ½Ç½Ã°£ °¡»ó ÁøÂû
    • ¿µ»ó ±â¹Ý
    • À½¼º ±â¹Ý
    • äÆÃ ±â¹Ý
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM)
    • ¸¸¼ºÁúȯ °ü¸®
    • ±Þ¼º±â ÈÄ Äɾî
    • ³ë³âÀÇÇÐ ¹× ¿ÏÈ­ÀÇ·á ¸ð´ÏÅ͸µ
  • Store-and-Forward ¼­ºñ½º
    • ¿ø°Ý ¹æ»ç¼± Áø´Ü
    • ¿ø°Ý ÇǺΰú
    • ¿ø°Ý º´¸®Áø´Ü

Á¦6Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× °¡»óÁø·á ½ÃÀå : Á¦°ø ¹æ½Äº°

  • Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû
    • SaaS ´ëÀÀ
    • EHR ÅëÇÕ
  • On-Premise ½Ã½ºÅÛ

Á¦7Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× °¡»óÁø·á ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¼ÒÇÁÆ®¿þ¾î
    • °¡»ó Áø·á Ç÷§Æû
    • AI ±â¹Ý ºÐ·ù ¹× ¿¹¾à ½Ã½ºÅÛ
    • µ¥ÀÌÅÍ ºÐ¼® ¹× º¸°í¼­ Åø
  • Çϵå¿þ¾î
  • ¼­ºñ½º
    • ¸Å´ÏÁöµå °¡»ó Äɾî ÇÁ·Î±×·¥
    • ÀÓ»ó ½ºÅÇ ¹èÄ¡ ¹× Áö¿ø
    • ¿ø°ÝÀÇ·á Áö¿ø ÄÁ¼³ÆÃ

Á¦8Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× °¡»óÁø·á ½ÃÀå : ¿ëµµº°

  • 1Â÷ÀÇ·á(Primary care)
    • ¿¹¹æ »ó´ã
    • º¹¾à Áؼö ÇÁ·Î±×·¥
  • Çൿ ¹× Á¤½Å°Ç°­
    • Ä¡·á ¹× »ó´ã
    • ¾à¹° ³²¿ë Áö¿ø
  • Àü¹® Äɾî
    • ½ÉÀ庴ÇÐ
    • ³»ºÐºñÇÐ
    • Á¾¾çÇÐ

Á¦9Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× °¡»óÁø·á ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø ¹× ÀÇ·á ½Ã½ºÅÛ
  • °³¾÷ÀÇ ¹× Ŭ¸®´Ð
  • °í¿ëÁÖ ¹× ÁöºÒÀÚ
  • ÀçÅÃÄ¡·á ¹× ȯÀÚ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦10Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× °¡»óÁø·á ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä µ¿Çâ

  • °è¾à, »ç¾÷ Á¦ÈÞ ¹× Çù·Â, ÇÕÀÛÅõÀÚ(JV)
  • ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®Àå
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Teladoc Health
  • Philips Healthcare
  • Amwell
  • Oracle Health
  • MDLIVE
  • GE HealthCare
  • CVS Health
  • Livi
  • UnitedHealth Group
  • Medgate
  • Amazon Clinic
  • HealthTap
  • Babylon Health
  • Ping An Good Doctor
  • Doctor On Demand
LSH 25.10.02

According to Stratistics MRC, the Global Telehealth & Virtual Care Market is accounted for $72.74 billion in 2025 and is expected to reach $372.94 billion by 2032 growing at a CAGR of 26.3% during the forecast period. Telehealth and Virtual Care involve providing medical services remotely using digital tools like mobile apps, video calls, and connected devices. These solutions make healthcare more accessible, reduce the need for in-person visits, and support better patient engagement. They also extend healthcare to rural and underserved communities, ensuring timely treatment while improving convenience and efficiency. As a modern healthcare approach, they foster continuity of care and optimize healthcare delivery systems

According to a Deloitte survey, just over half (53%) of consumers believe generative AI will improve access to healthcare, and 46% think AI will reduce the costs of medications and treatments to make healthcare more affordable to everyday Americans.

Market Dynamics:

Driver:

Rising demand for accessible and cost-effective healthcare solutions

The growing need for affordable and easily accessible healthcare is propelling the adoption of telehealth and virtual care platforms. As populations age and chronic conditions rise, patients and providers alike are seeking alternatives to traditional in-person visits. Digital health tools are bridging gaps in rural and underserved areas, offering timely consultations without geographic constraints. The expansion of mobile networks and smartphone penetration further supports this shift toward virtual care. Governments and insurers are increasingly recognizing the value of remote services in reducing hospital burden and improving outcomes. This surge in demand is accelerating innovation and investment across the telehealth ecosystem.

Restraint:

Data privacy and cybersecurity concerns

Telehealth platforms face mounting scrutiny over data protection and cybersecurity vulnerabilities. Handling sensitive patient information requires strict compliance with privacy regulations such as HIPAA and GDPR. Integration with legacy systems and third-party apps can expose platforms to breaches and unauthorized access. The complexity of securing cloud-based consultations and wearable device data adds to operational challenges. Providers must invest in encryption, multi-factor authentication, and regular audits to maintain trust. These concerns may slow adoption rates, especially in regions with stringent legal frameworks or low digital literacy.

Opportunity:

Integration of wearable devices for continuous patient monitoring

The convergence of wearable technology and virtual care is unlocking new possibilities for proactive health management. Devices like smartwatches, biosensors, and fitness trackers enable real-time monitoring of vital signs, activity levels, and medication adherence. This data can be seamlessly integrated into telehealth platforms, allowing clinicians to make informed decisions remotely. Continuous monitoring supports early detection of complications and personalized treatment plans. As AI and predictive analytics evolve, wearables will play a central role in chronic disease management and preventive care. The growing consumer interest in health tech is expected to drive significant market expansion in this area.

Threat:

Risk of misdiagnosis due to limited physical examination

Certain conditions require tactile evaluation, imaging, or lab tests that cannot be conducted remotely. Over-reliance on patient-reported symptoms and video consultations may result in incomplete clinical insights. This risk is particularly pronounced in complex or acute cases where subtle signs are easily missed. Providers must balance convenience with clinical rigor, often referring patients for in-person follow-ups. Without proper protocols and escalation pathways, the credibility of telehealth services may be undermined.

Covid-19 Impact

The COVID-19 pandemic dramatically accelerated the adoption of telehealth, transforming it from a niche offering into a mainstream healthcare solution. Lockdowns and social distancing mandates forced providers to pivot toward remote consultations to maintain continuity of care. Patients embraced virtual platforms for safety and convenience, leading to a surge in usage across demographics. Regulatory bodies temporarily relaxed restrictions, enabling broader reimbursement and cross-border practice. Post-pandemic strategies now emphasize hybrid care models, resilience, and long-term integration of virtual services.

The real-time virtual consultations segment is expected to be the largest during the forecast period

The real-time virtual consultations segment is expected to account for the largest market share during the forecast period, due to its ability to deliver immediate care across diverse medical needs. Patients benefit from instant access to physicians, reducing wait times and avoiding unnecessary travel. This format supports primary care, mental health, and follow-up visits, making it highly versatile. Integration with electronic health records and scheduling systems enhances workflow efficiency for providers. As reimbursement models evolve and user experience improves, real-time consultations are becoming the preferred mode of interaction. Their scalability and responsiveness position them as the cornerstone of virtual care delivery.

The homecare & patients segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the homecare & patients segment is predicted to witness the highest growth rate, driven by rising demand for personalized and remote health services. Aging populations and chronic disease prevalence are fuelling interest in home-based monitoring and virtual support. Telehealth enables patients to manage conditions like diabetes, hypertension, and COPD from the comfort of their homes. Advances in remote diagnostics and mobile health apps are empowering individuals to take control of their wellness. Caregivers and family members also benefit from improved coordination and real-time updates. This segment's growth reflects a broader shift toward decentralized, patient-centric care models.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to its vast population and growing healthcare digitization. Countries like China, India, and Japan are investing heavily in telemedicine infrastructure to address rural access gaps and urban congestion. Government initiatives promoting digital health and mobile-first strategies are accelerating adoption. The region's tech-savvy consumers and expanding middle class are driving demand for convenient healthcare solutions. Partnerships between public and private sectors are fostering innovation and scalability.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by advanced technology integration and supportive policy frameworks. The U.S. and Canada are leading in AI-enabled diagnostics, remote patient monitoring, and virtual behavioural health services. Federal funding and insurance reforms are encouraging widespread adoption across hospitals and clinics. Start-ups and established players alike are innovating in user experience, interoperability, and data analytics. Rising healthcare costs and provider shortages are pushing stakeholders toward scalable virtual solutions. With a mature digital ecosystem, North America is setting benchmarks for telehealth innovation and growth.

Key players in the market

Some of the key players profiled in the Telehealth & Virtual Care Market include Teladoc Health, Philips Healthcare, Amwell, Oracle Health, MDLIVE, GE HealthCare, CVS Health, Livi, UnitedHealth Group, Medgate, Amazon Clinic, HealthTap, Babylon Health, Ping An Good Doctor, and Doctor On Demand.

Key Developments:

In January 2025, Teladoc Health teamed up with Amazon to improve chronic condition management via the Amazon Health Benefits Connector.

In October 2024, Zoom partnered with Suki AI to incorporate AI for clinical documentation, while Masimo and Philips expanded their collaboration in January 2023 to integrate the Masimo W1 health tracker into home telehealth.

Service Types Covered:

  • Real-Time Virtual Consultations
  • Remote Patient Monitoring (RPM)
  • Store-and-Forward Services

Delivery Modes Covered:

  • Cloud-Based Platforms
  • On-Premise Systems

Components Covered:

  • Software
  • Hardware
  • Services

Applications Covered:

  • Primary Care
  • Behavioral & Mental Health
  • Specialty Care

End Users Covered:

  • Hospitals & Health Systems
  • Physician Practices & Clinics
  • Employers & Payers
  • Homecare & Patients
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Telehealth & Virtual Care Market, By Service Type

  • 5.1 Introduction
  • 5.2 Real-Time Virtual Consultations
    • 5.2.1 Video-based
    • 5.2.2 Audio-based
    • 5.2.3 Chat-based
  • 5.3 Remote Patient Monitoring (RPM)
    • 5.3.1 Chronic Disease Management
    • 5.3.2 Post-Acute Care
    • 5.3.3 Geriatric & Palliative Monitoring
  • 5.4 Store-and-Forward Services
    • 5.4.1 Teleradiology
    • 5.4.2 Teledermatology
    • 5.4.3 Telepathology

6 Global Telehealth & Virtual Care Market, By Delivery Mode

  • 6.1 Introduction
  • 6.2 Cloud-Based Platforms
    • 6.2.1 SaaS-enabled
    • 6.2.2 EHR-integrated
  • 6.3 On-Premise Systems

7 Global Telehealth & Virtual Care Market, By Component

  • 7.1 Introduction
  • 7.2 Software
    • 7.2.1 Virtual Care Platforms
    • 7.2.2 AI-Powered Triage & Scheduling
    • 7.2.3 Data Analytics & Reporting Tools
  • 7.3 Hardware
  • 7.4 Services
    • 7.4.1 Managed Virtual Care Programs
    • 7.4.2 Clinical Staffing & Support
    • 7.4.3 Telehealth Enablement Consulting

8 Global Telehealth & Virtual Care Market, By Application

  • 8.1 Introduction
  • 8.2 Primary Care
    • 8.2.1 Preventive Consultations
    • 8.2.2 Medication Adherence Programs
  • 8.3 Behavioral & Mental Health
    • 8.3.1 Therapy & Counseling
    • 8.3.2 Substance Abuse Support
  • 8.4 Specialty Care
    • 8.4.1 Cardiology
    • 8.4.2 Endocrinology
    • 8.4.3 Oncology

9 Global Telehealth & Virtual Care Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Health Systems
  • 9.3 Physician Practices & Clinics
  • 9.4 Employers & Payers
  • 9.5 Homecare & Patients
  • 9.6 Other End Users

10 Global Telehealth & Virtual Care Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Teladoc Health
  • 12.2 Philips Healthcare
  • 12.3 Amwell
  • 12.4 Oracle Health
  • 12.5 MDLIVE
  • 12.6 GE HealthCare
  • 12.7 CVS Health
  • 12.8 Livi
  • 12.9 UnitedHealth Group
  • 12.10 Medgate
  • 12.11 Amazon Clinic
  • 12.12 HealthTap
  • 12.13 Babylon Health
  • 12.14 Ping An Good Doctor
  • 12.15 Doctor On Demand
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦